Navigation Links
Switzerland to stock bird flu vaccine

Switzerland has placed an order for a stock of GlaxoSmithKline Plc's experimental bird flu vaccine for human, enough to protect its entire population.//

According to the Europe’s biggest drug company, the Swiss Federal Office of Public Health had ordered 8 million doses of its H5N1 vaccine for protection against influenza pandemic which can be activated by bird flu.

After the review and approval of the regulatory file for the pre-pandemic vaccine by the Swiss regulatory agency, Swissmedic, the vaccine will be supplied and stored by near the beginning of next year.

According to Glaxo, it is in discussion with other countries in Europe on pandemic preparation plans and will file its vaccine for approval with the European Medicines Agency by the end of this year. As Glaxo’s vaccine needs a very small amount of the key ingredient, even limited supplies would be enough to vaccinate many.

The major challenge faced by the drug companies is to use the minimum amount of the active ingredient or the antigen to produce maximum number of vaccines. Though Glaxo’s vaccine is effective against the lethal H5N1 avian flu virus, its action against any mutated strain is not known.

The H5N1 strain has quickly spread beyond Asia and has claimed over 150 lives of those who were in close contact with the infected birds.

If the virus attains the ability to transmit from human to human, experts dread that it can give rise to a global epidemic of flu that could take millions of lives.

Other companies in the race to develop pandemic H5N1 vaccines are Sanofi-Aventis, Novartis AG and Baxter International Inc.
GT
'"/>




Page: 1

Related medicine news :

1. Chandy Undergoes Surgery In Switzerland
2. Bird Flu Now Spreads to Switzerland
3. Number Of Bird Flu Cases In Switzerland Reaches 11
4. Risk of deep vein thrombosis less in people who were flight stockings when flying
5. Health and Human Services stockpiles 20 million bird flu Vaccines
6. Rich countries stock piling anti flu drugs with no stocks available for poor countries
7. Bird flu: the threat causes lowering in poultry stocks
8. Time is ripe to take stock of depression
9. Burma Restocks Poultry Farms Again
10. Depleting stock of antiretroviral drugs in Uganda raises concern
11. Companies ensure enough stock of bird flu drug

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Switzerland stock bird flu vaccine

(Date:12/4/2009)...mption leads to success, study finds , ,...ercise, reduced soda consumption and self-weighing...egies for adolescents, a new study shows. , Res...ht-control strategies and lifestyle habits. Sixty-... The responses were grouped into four categories: ...
(Date:12/4/2009)...oric Effort but Points out Potential Risk if Ameri...Care Reform ,, NEW YORK, Dec. 4 /PRNewswire-U...e today published a Perspective opinion piece ad...Redlener, M.D., president, Children,s Health Fund ...dness and Professor of Clinical Population & F...
(Date:12/4/2009)...wn as statins are among the most prescribed medici...Fred Hutchinson Cancer Research Center indicates t...nts from one of the most serious complications of ...disease, or GVHD. The findings are reported in the...n a retrospective study of 567 patients who underw...
(Date:12/4/2009)... growth after heart attack , , FRIDAY, D...to help repair heart attack damage, a new study sh...hat stem cells from donor bone marrow promoted the...ed by heart attack. , The patients received the...eart attack. During follow-up, they were compared ...
(Date:12/4/2009)... 4 Today, seven of Florida,s top n...ing the health of Florida,s uninsured and underser... 2009 Sapphire Award ceremony. ,, The Sapphire ...nizes and promotes organizations that have demonst...within their communities. ,, Honorees of The 20...
Breaking Medicine News(10 mins):Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3
...s Corp. (Nasdaq:,HMSY) today announced that it wil...onference, which will be held January 7-10, 2008 a...: http://www.newscom.com/cgi-bin/prnh/20030304/NY...ast of the Company,s presentation can be accessed ...
...nix,Pharmaceuticals, Inc. (Nasdaq: IDIX ) announc...porate overview, including an update of the compan..., at the upcoming JP Morgan 26th,Annual Healthcare...entation can be accessed,under "Calendar of Events...
...am for Lead Product, MENLO PARK, Calif., Dec. 20 ...t it has completed a private placement financing,r...opment of the company,s,novel antiplatelet therapy...on,from Prospect Venture Partners, Ridgeback Capit...
...-Opportunities program of Agriculture and ..., ON, Dec. 20 /PRNewswire-FirstCall/ - Bioniche Li...hnology-driven Canadian,biopharmaceutical company,... Ontario. The $5 million repayable,contribution ha...
..., 2007 Wiley-Blackwell, the scientific, technical...n Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), and ...anisation dedicated to improving healthcare decisi...World Banks list of low-income economies (countrie...
...dds, study found , THURSDAY, Dec. 20 (HealthDay Ne...cy can boost a child,s risk of developing allergie...nska Institute, Stockholm, analyzed questionnaires...s, 2 years and 4 years. In addition, the researche...
Other Medicine News:Health News:Cogentus Pharmaceuticals Completes $62.5 Million Private Financing 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 3Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 4Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 5Health News:Low-income countries now have free, one-click access to Cochrane Library 2Health News:Parents' Smoking Boosts Child's Allergy Risk 2
(Date:12/4/2009)..., ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/ -...se company developing medical countermeasures agai...ay the presentation of new data from the Company,s...zed recombinant Protective Antigen (rPA) based ant...er 16 months at various temperatures up to and inc...
(Date:12/4/2009)..., SAN DIEGO, Calif., Dec. 4 Sunev...ce company, today announced the appointment of Phi...fficer. In this role, Mr. Ranker will lead all Su...s including finance, accounting, IT, IR, administr...the Company,s senior management team. ,, "One ...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 Drs. Neal ...prostate-specific antigen (PSA) recurrence from th...iochemical recurrence rate in a Phase III pivotal ...ection) or monthly leuprolide in prostate cancer p...ate cancer patients who received FIRMAGON 240/80 m...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Middle Age Heart Risk Factors Shorten Mens Lives 57598 1Middle Age Heart Risk Factors Shorten Mens Lives 57598 2Middle Age Heart Risk Factors Shorten Mens Lives 57598 3Northwest Hospital 26 Medical Center to Join UW Medicine 57596 1Northwest Hospital 26 Medical Center to Join UW Medicine 57596 2Northwest Hospital 26 Medical Center to Join UW Medicine 57596 3U S Chamber 3A Medical Liability Reform Must Have Teeth to be Effective 57594 1
...r and Imaging Study) Results Demonstrate ...SAN DIEGO, Calif., Sept. 2 Volcano,Corporation (N...nufacturer of,intravascular ultrasound (IVUS) and ...oday the use of its VH(R) IVUS (Virtual Histology ...d Biomarker and Imaging Study). In,the study, Volc...
...sty and Stenting Safe and Effective in Patients ...t Surgery, WASHINGTON, Sept. 1 Data announced to...atients with very complex coronary,artery disease ...nd,drug-eluting stents rather than open-heart surg...hy and Interventions (SCAI). The one-year results,...
Other Medicine Technology:Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 2Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 3Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 4SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease 2SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease 3
DuraSeal Dural Sealant
Mastisol Liquid Adhesive
GluStitch® Monograph
Marquette T-Wave Alternans (TWA) Analysis
Medicine Products: